2024MAY03: Our hosting provider has resolved some DB connectivity issues. We may experience some more outages as the issue is resolved. We apologize for the inconvenience. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop.

Cancer cell | 2022

The lack of T cell infiltrates is a major obstacle to effective immunotherapy in cancer. Conversely, the formation of tumor-associated tertiary-lymphoid-like structures (TA-TLLSs), which are the local site of humoral and cellular immune responses against cancers, is associated with good prognosis, and they have recently been detected in immune checkpoint blockade (ICB)-responding patients. However, how these lymphoid aggregates develop remains poorly understood. By employing single-cell transcriptomics, endothelial fate mapping, and functional multiplex immune profiling, we demonstrate that antiangiogenic immune-modulating therapies evoke transdifferentiation of postcapillary venules into inflamed high-endothelial venules (HEVs) via lymphotoxin/lymphotoxin beta receptor (LT/LTβR) signaling. In turn, tumor HEVs boost intratumoral lymphocyte influx and foster permissive lymphocyte niches for PD1- and PD1+TCF1+ CD8 T cell progenitors that differentiate into GrzB+PD1+ CD8 T effector cells. Tumor-HEVs require continuous CD8 and NK cell-derived signals revealing that tumor HEV maintenance is actively sculpted by the adaptive immune system through a feed-forward loop.

Pubmed ID: 36423635 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: R01 CA201537

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Anti-ERG antibody (antibody)

RRID:AB_2630401

This monoclonal targets

View all literature mentions

InVivoPlus anti-mouse CTLA-4 (CD152) (antibody)

RRID:AB_10949609

This monoclonal targets CTLA-4 (CD152)

View all literature mentions

InVivoPlus anti-mouse PD-L1 (B7-H1) (antibody)

RRID:AB_10949073

This monoclonal targets PD-L1 (B7-H1)

View all literature mentions

InVivoPlus anti-mouse VEGFR-2 (antibody)

RRID:AB_1107766

This monoclonal targets VEGFR-2

View all literature mentions

InVivoPlus anti-mouse IFNγ (antibody)

RRID:AB_1107694

This monoclonal targets IFNγ

View all literature mentions

InVivoPlus anti-mouse NK1.1 (antibody)

RRID:AB_1107737

This monoclonal targets NK1.1

View all literature mentions

rat IgG2b I sotype control (antibody)

RRID:AB_1107780

This isotype control targets KLH

View all literature mentions

anti-mouse CD8α (antibody)

RRID:AB_1125541

This monoclonal targets CD8α

View all literature mentions

anti-mouse CD4 (antibody)

RRID:AB_1107636

This monoclonal targets CD4

View all literature mentions

InVivoPlus anti-mouse CSF1R (CD115) (antibody)

RRID:AB_2687699

This monoclonal targets CSF1R (CD115)

View all literature mentions

Perforin antibody [5B10] (antibody)

RRID:AB_2042606

This monoclonal targets Human Perforin

View all literature mentions

Human/Mouse Desmin Affinity Purified Polyclonal Ab (antibody)

RRID:AB_2092419

This polyclonal targets Human/Mouse Desmin Affinity Purified Ab

View all literature mentions

PE/Cyanine5 anti-mouse TCR beta chain (antibody)

RRID:AB_313432

This monoclonal targets TCR beta chain

View all literature mentions

Recombinant Anti-TIM 3 antibody [EPR22241] (antibody)

RRID:AB_2888936

This recombinant monoclonal targets TIM-3

View all literature mentions

CD25 (IL-2 Receptor α) (antibody)

RRID:AB_2739522

This monoclonal targets CD25 (IL-2 Receptor α)

View all literature mentions

CD317 (PDCA-1)-PerCP-Vio700, mouse (antibody)

RRID:AB_2657408

This monoclonal targets CD317 (PDCA-1)

View all literature mentions

BUV737 Rat Anti-Mouse IFN-γ (antibody)

RRID:AB_2722494

This monoclonal targets IFN-γ

View all literature mentions

Purified anti-mouse NK-1.1 (antibody)

RRID:AB_313389

This monoclonal targets NK-1.1

View all literature mentions

PD-1 (D4W2J) XP® (antibody)

RRID:AB_2728833

This monoclonal targets PD-1

View all literature mentions

CD45 (antibody)

RRID:AB_2739420

This monoclonal targets CD45

View all literature mentions

APC anti-mouse CD45 (antibody)

RRID:AB_312977

This monoclonal targets CD45

View all literature mentions

FoxP3 Antibody, anti-mouse, APC, REAfinity™ (antibody)

RRID:AB_2651768

This recombinant monoclonal targets FoxP3

View all literature mentions

APC anti-mouse CD3 (antibody)

RRID:AB_2561456

This monoclonal targets CD3

View all literature mentions

BUV496 Rat Anti-Mouse CD4 (antibody)

RRID:AB_2722549

This monoclonal targets mouse CD4

View all literature mentions

CD8-alpha (C8/144B) (antibody)

RRID:AB_1120718

This monoclonal targets Human CD8A

View all literature mentions

BUV805 Rat Anti-Mouse CD8a (antibody)

RRID:AB_2716856

This monoclonal targets CD8 alpha

View all literature mentions

APC anti-mouse CD8a (antibody)

RRID:AB_312751

This monoclonal targets CD8a

View all literature mentions

Anti-Human Von Willebrand Factor Antibody (antibody)

RRID:AB_2315602

This polyclonal targets Von Willebrand Factor

View all literature mentions

CD62P (P-Selectin) (antibody)

RRID:AB_2738366

This monoclonal targets CD62P (P-Selectin)

View all literature mentions

MS CD62E PURE MAB 0.5MG 10E9.6 (antibody)

RRID:AB_2186705

This monoclonal targets CD62E (E-Selectin)

View all literature mentions

MECA-79 (MECA-79) (antibody)

RRID:AB_627143

This monoclonal targets Mouse N/A

View all literature mentions

APC anti-mouse CD31 (antibody)

RRID:AB_312905

This monoclonal targets CD31

View all literature mentions

Anti-CD31 antibody (antibody)

RRID:AB_726362

This polyclonal targets CD31

View all literature mentions